Search Results - "Wang, Xin W."

Refine Results
  1. 1

    Genomic perturbations reveal distinct regulatory networks in intrahepatic cholangiocarcinoma by Nepal, Chirag, O'Rourke, Colm J., Oliveira, Douglas V.N.P., Taranta, Andrzej, Shema, Steven, Gautam, Prson, Calderaro, Julien, Barbour, Andrew, Raggi, Chiara, Wennerberg, Krister, Wang, Xin W., Lautem, Anja, Roberts, Lewis R., Andersen, Jesper B.

    Published in Hepatology (Baltimore, Md.) (01-09-2018)
    “…Intrahepatic cholangiocarcinoma remains a highly heterogeneous malignancy that has eluded effective patient stratification to date. The extent to which such…”
    Get full text
    Journal Article
  2. 2

    Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival by Tang, Wei, Zhou, Ming, Dorsey, Tiffany H, Prieto, DaRue A, Wang, Xin W, Ruppin, Eytan, Veenstra, Timothy D, Ambs, Stefan

    Published in Genome medicine (03-12-2018)
    “…Transcriptome analysis of breast cancer discovered distinct disease subtypes of clinical significance. However, it remains a challenge to define disease…”
    Get full text
    Journal Article
  3. 3

    Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer by Cairo, Stefano, Wang, Yipeng, de Reyniès, Aurélien, Duroure, Karine, Dahan, Jennifer, Redon, Marie-José, Fabre, Monique, McClelland, Michael, Wang, Xin W., Croce, Carlo M., Buendia, Marie-Annick, Vogt, Peter K.

    “…Myc activation has been implicated in the pathogenesis of hepatoblastoma (HB), a rare embryonal neoplasm derived from liver progenitor cells. Here, microRNA…”
    Get full text
    Journal Article
  4. 4

    Identification of drivers from cancer genome diversity in hepatocellular carcinoma by Takai, Atsushi, Dang, Hien T, Wang, Xin W

    “…Hepatocellular carcinoma (HCC) is one of the most common cancers with a dismal outcome. The complicated molecular pathogenesis of HCC caused by tumor…”
    Get full text
    Journal Article
  5. 5

    Wnt/beta-catenin signaling activates microRNA-181 expression in hepatocellular carcinoma by Ji, Junfang, Yamashita, Taro, Wang, Xin W

    Published in Cell & bioscience (18-01-2011)
    “…Hepatocellular carcinoma (HCC) is a malignant cancer with an observable heterogeneity and microRNAs are functionally associated with the tumorigenesis of HCC…”
    Get full text
    Journal Article
  6. 6

    The clinical potential of microRNAs by Budhu, Anuradha, Ji, Junfang, Wang, Xin W

    Published in Journal of hematology and oncology (06-10-2010)
    “…MicroRNAs are small noncoding RNAs that function to control gene expression. These small RNAs have been shown to contribute to the control of cell growth,…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches by Greten, Tim F, Wang, Xin W, Korangy, Firouzeh

    Published in Gut (01-05-2015)
    “…The recent approval of two immune checkpoint inhibitors for the treatment of malignant melanoma has sparked great interest by physicians and basic scientists…”
    Get more information
    Journal Article
  12. 12

    Immunology and immunotherapy of cholangiocarcinoma by Greten, Tim F., Schwabe, Robert, Bardeesy, Nabeel, Ma, Lichun, Goyal, Lipika, Kelley, Robin K., Wang, Xin W.

    “…Cholangiocarcinoma is the second most common primary liver cancer. Its incidence is low in the Western world but is rising globally. Surgery, chemotherapy and…”
    Get full text
    Journal Article
  13. 13

    Understanding tumour cell heterogeneity and its implication for immunotherapy in liver cancer using single-cell analysis by Heinrich, Sophia, Craig, Amanda J., Ma, Lichun, Heinrich, Bernd, Greten, Tim F., Wang, Xin W.

    Published in Journal of hepatology (01-03-2021)
    “…Over the last decade, precision medicine and immunotherapeutic approaches have become increasingly popular in oncology. Early clinical trials reported…”
    Get full text
    Journal Article
  14. 14

    Biomarkers for immunotherapy of hepatocellular carcinoma by Greten, Tim F., Villanueva, Augusto, Korangy, Firouzeh, Ruf, Benjamin, Yarchoan, Mark, Ma, Lichun, Ruppin, Eytan, Wang, Xin W.

    Published in Nature reviews. Clinical oncology (01-11-2023)
    “…Immune-checkpoint inhibitors (ICIs) are now widely used for the treatment of patients with advanced-stage hepatocellular carcinoma (HCC). Two different…”
    Get full text
    Journal Article
  15. 15

    MiR‐125b Loss Activated HIF1α/pAKT Loop, Leading to Transarterial Chemoembolization Resistance in Hepatocellular Carcinoma by Wei, Xiyang, Zhao, Lei, Ren, Ruizhe, Ji, Fubo, Xue, Shuting, Zhang, Jianjuan, Liu, Zhaogang, Ma, Zhao, Wang, Xin W., Wong, Linda, Liu, Niya, Shi, Jiong, Guo, Xing, Roessler, Stephanie, Zheng, Xin, Ji, Junfang

    Published in Hepatology (Baltimore, Md.) (01-04-2021)
    “…Background and Aims Transarterial chemoembolization (TACE) is a standard locoregional therapy for patients with hepatocellular carcinoma (HCC) patients with a…”
    Get full text
    Journal Article
  16. 16

    Involvement of Crm1 in Hepatitis B Virus X Protein-Induced Aberrant Centriole Replication and Abnormal Mitotic Spindles by Forgues, Marshonna, Difilippantonio, Michael J., Linke, Steven P., Ried, Thomas, Nagashima, Kunio, Feden, Jeffrey, Valerie, Kristoffer, Fukasawa, Kenji, Wang, Xin W.

    Published in Molecular and Cellular Biology (01-08-2003)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  17. 17

    The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress by STAIB, Frank, ROBLES, Ana I, GALLE, Peter R, HARRIS, Curtis C, VARTICOVSKI, Lyuba, WANG, Xin W, ZEEBERG, Barry R, SIROTIN, Michail, ZHURKIN, Victor B, HOFSETH, Lorne J, HUSSAIN, S. Perwez, WEINSTEIN, John N

    Published in Cancer research (Chicago, Ill.) (15-11-2005)
    “…Activation of the p53 network plays a central role in the inflammatory stress response associated with ulcerative colitis and may modulate cancer risk in…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Loading and Unloading: Orchestrating Centrosome Duplication and Spindle Assembly by Ran/Crm1 by Budhu, Anuradha S., Wang, Xin W.

    Published in Cell cycle (Georgetown, Tex.) (01-11-2005)
    “…The cell cycle is an intricate process of DNA replication and cell division thatconcludes with the formation of two genetically equivalent daughter cells. In…”
    Get full text
    Journal Article
  20. 20

    Hepatitis B Virus X Protein and p53 Tumor Suppressor Interactions in the Modulation of Apoptosis by Elmore, L W, Hancock, A R, Chang, S F, Wang, X W, Chang, S, Callahan, C P, Geller, D A, Will, H, Harris, C C

    “…We have reported previously that the hepatitis B virus oncoprotein, HBx, can bind to the C terminus of p53 and inhibit several critical p53-mediated cellular…”
    Get full text
    Journal Article